| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/04/2001 | EP0821665B1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase |
| 10/04/2001 | EP0815081B1 Piperidinyl-2-alkyl substituted linear polyamines for the reduction of intracellular, endogenic polyamine levels such as putrescine, spermidine and spermine, and their impact on cell proliferation |
| 10/04/2001 | EP0639979B1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 10/04/2001 | EP0552329B1 Methylen-oxindole derivatives and process for their preparation |
| 10/04/2001 | EP0529002B1 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes |
| 10/04/2001 | DE19947154A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 10/04/2001 | CA2659030A1 Methods for inhibiting angiogenesis and tumor growth |
| 10/04/2001 | CA2429196A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 10/04/2001 | CA2407036A1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide |
| 10/04/2001 | CA2404780A1 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 10/04/2001 | CA2404712A1 Synergistic methods and compositions for treating cancer comprising antiproliferative cytotoxic and cytostatic agents |
| 10/04/2001 | CA2404662A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 10/04/2001 | CA2404626A1 Novel piperazine derivatives |
| 10/04/2001 | CA2404570A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 10/04/2001 | CA2404563A1 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 10/04/2001 | CA2404532A1 Method of identifying inhibitors of tie-2 |
| 10/04/2001 | CA2404528A1 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 10/04/2001 | CA2404495A1 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 10/04/2001 | CA2404478A1 Glycosaminoglycans derived from the k5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation |
| 10/04/2001 | CA2404448A1 Genes involved in intestinal inflammatory diseases and use thereof |
| 10/04/2001 | CA2404445A1 Tricyclic protein kinase inhibitors |
| 10/04/2001 | CA2404432A1 Compositions and methods for identifying and targeting cancer cells |
| 10/04/2001 | CA2404428A1 High specificity marker detection |
| 10/04/2001 | CA2404411A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 10/04/2001 | CA2404390A1 Methods of therapy for non-hodgkin's lymphoma using a combination of an antibody to cd20 and interleukin-2 |
| 10/04/2001 | CA2404374A1 Use of metal salts to stabilize taxane-based compositions |
| 10/04/2001 | CA2404370A1 Taxane-based compositions and methods of use |
| 10/04/2001 | CA2404233A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 10/04/2001 | CA2404231A1 Methods of treating diseases with activated protein c |
| 10/04/2001 | CA2404172A1 Antiprogestins with partial agonist activity |
| 10/04/2001 | CA2404164A1 Compositions and methods for enhancing immunogenicity of antigens |
| 10/04/2001 | CA2404147A1 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract |
| 10/04/2001 | CA2404100A1 Therapeutic peptides having a motif that binds specifically to non-acetylated h3 and h4 histones for cancer therapy |
| 10/04/2001 | CA2404085A1 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising uroplakin-specific transcriptional regulatory sequences, and methods of use thereof |
| 10/04/2001 | CA2404060A1 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation |
| 10/04/2001 | CA2403909A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 10/04/2001 | CA2403857A1 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 10/04/2001 | CA2403814A1 Polyamine analogues as cytotoxic agents |
| 10/04/2001 | CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 10/04/2001 | CA2403787A1 Il-8 receptor antagonists |
| 10/04/2001 | CA2403764A1 Methods for immunostimulation using binding agents for the fc receptor of immunoglobulin a |
| 10/04/2001 | CA2403637A1 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 10/04/2001 | CA2403515A1 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 10/04/2001 | CA2403297A1 Docosahexaenoic acid as retinoid x receptor and uses thereof |
| 10/04/2001 | CA2402780A1 Insulin and igf-1 receptor agonists and antagonists |
| 10/04/2001 | CA2402769A1 Ceramide derivatives and method of use |
| 10/04/2001 | CA2402735A1 Human transcription factors |
| 10/04/2001 | CA2402453A1 Compounds for targeting |
| 10/04/2001 | CA2402439A1 Methods of modulating drug clearance mechanisms by altering sxr activity |
| 10/04/2001 | CA2402187A1 Intracorporeal medicaments comprising halogenated xanthene for photodynamic treatment of disease |
| 10/04/2001 | CA2401748A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
| 10/04/2001 | CA2400573A1 Alteration of cellular behavior by antisense modulation of mrna processing |
| 10/04/2001 | CA2399875A1 Crystal structure of the (aml1 runt domain) / (cbfbeta) heterodimer and the ternary complex with dna |
| 10/04/2001 | CA2399864A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 10/04/2001 | CA2399287A1 Beta-glucans from filamentous fungi |
| 10/04/2001 | CA2374911A1 G-protein coupled receptors |
| 10/03/2001 | CN1315998A Compositions and methods for therapy and diagnosis of prostate cancer |
| 10/03/2001 | CN1315967A Bifunctional antibodies and their use in targeting anti-tumour agents |
| 10/03/2001 | CN1315966A High-affinity antibodies |
| 10/03/2001 | CN1315869A Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 10/03/2001 | CN1315866A Method of modulating memory effector T-cells using CD2-binding agent, and compositions |
| 10/03/2001 | CN1315863A Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process |
| 10/03/2001 | CN1315563A Polypeptide-human endoprotease 11 and polynucleotide for coding it |
| 10/03/2001 | CN1315561A Polypeptide-human ATP-dependent serine protein hydrolase 9 and polynucleotide for coding it |
| 10/03/2001 | CN1315544A Polypeptide-unwindase 16 and polynucleotide for coding it |
| 10/03/2001 | CN1315529A Polypeptide-human quinoprotein reductase 9 and polynucleotide for coding it |
| 10/03/2001 | CN1315525A Polypeptide-human quinoprotein reductase 18 and polynucleotide for coding it |
| 10/03/2001 | CN1315519A Polypeptide-human pterin Mo oxido-reductase 10 and polynucleotide for coding it |
| 10/03/2001 | CN1315500A Process for preparing human angiostatin transgenic alga |
| 10/03/2001 | CN1315445A Polypeptide-human gap bindin 8 and polynucleotide for coding it |
| 10/03/2001 | CN1315444A Polypeptide-human gap bindin 10 and polynucleotide for coding it |
| 10/03/2001 | CN1315443A Polypeptide-human cell differentiation transcription factor 10 and polynucleotide for coding it |
| 10/03/2001 | CN1315438A Polypeptide human carbon's metabolic by-product repression protein related protein 16 and polynucleotide for coding it |
| 10/03/2001 | CN1315432A Polypeptide-human flavoprotein subunit 15 and polynucleotide for coding it |
| 10/03/2001 | CN1315422A Polypeptide-human zinc finger protein 49 and polynucleotide for coding it |
| 10/03/2001 | CN1315417A Polypeptide-human protein phosphatase 1 regulating protein 12 and polynucleotide for coding it |
| 10/03/2001 | CN1315410A Polypeptide-human cell differentiation transcription factor 16 and polynucleotide for coding it |
| 10/03/2001 | CN1315406A Polypeptide-human transducin 10 and polynucleotide for coding it |
| 10/03/2001 | CN1315405A Polypeptide-human zinc finger protein 15 and polynucleotide for coding it |
| 10/03/2001 | CN1315402A Polypeptide-human amyloid precursor protein bindin 14 and polynucleotide for coding it |
| 10/03/2001 | CN1315399A Polypeptide-human proteolytic enzyme regulating protein 12 and polynucleotide for coding it |
| 10/03/2001 | CN1315398A Polypeptide-human S4 ribosome protein 15 and polynucleotide for coding it |
| 10/03/2001 | CN1315394A Polypeptide-human nuclear transform protein 13 containing ATP/GTP-binding structure domain and polynucleotide for coding it |
| 10/03/2001 | CN1315377A Polypeptide-human Na-Hg subunit 12 and polynucleotide for coding it |
| 10/03/2001 | CN1315370A Polypeptide-human uteroglobin 11 and polynucleotide for coding it |
| 10/03/2001 | CN1315353A Polypeptide-human amyloid gycoprotein 9 and polynucleotide for coding it |
| 10/03/2001 | CN1315326A Cisplatinun dinuclear platinum complex for treating cancer and its therapeutic method |
| 10/03/2001 | CN1072220C 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derives as neurokinin receptor antagonists |
| 10/03/2001 | CN1072210C 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors |
| 10/02/2001 | US6297371 Cytolysing raw cells, applying to anion exchanger which begins desorbing dna and rna at different ionic strengths, then eluting nucleic acids and/or oligonucleotides; treating preparation at first or last step to remove endotoxin |
| 10/02/2001 | US6297367 Polynucleotide encoding TNFL1 |
| 10/02/2001 | US6297364 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 10/02/2001 | US6297361 Use of histidine decarboxylase immunoreactivity to detect human cancer |
| 10/02/2001 | US6297357 prb2/p130 peptide inhibitors of cdk2 kinase activity |
| 10/02/2001 | US6297281 Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 10/02/2001 | US6297277 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 10/02/2001 | US6297266 Inhibit the binding of adhesive proteins to the surface of different types of cell and accordingly influence cell-cell and cell-matrix interactions. |
| 10/02/2001 | US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 10/02/2001 | US6297250 Useful for inhibiting transport of nucleosides or purines across cell membranes, thereby to potentiate the activity of various cytotoxic antitumor drugs |
| 10/02/2001 | US6297239 Inhibitors of prenyl-protein transferase |